WHERE CUTTING EDGE INNOVATION AND COLLABORATION COME TOGETHER

Afrigen is a technology platform based biotech company. Learn more about our platforms:
Artboard 1platform division

The objective of the technology transfer hub is to build mRNA vaccine production capacity in low- and middle-income countries through a center of excellence and training.

Vaccines are derived from killed, inactivated, or sub-unit bacteria or viruses, producing an immune response and providing immunity. Find out more about our developments and technology.

Encapsulation technologies extend shelf life, reduce evaporation and degradation, prevent interactions, improve sensory traits, control bioactive release, and enhance bioavailability.

High-quality products with complex pure and botanical mixtures, offering clinicians less-invasive, cost-effective therapeutic solutions for dosing and delivery of medicinal actives.

AFRIGEN IS MAKING HEADLINES

Please see below articles on where we have been featuring world wide. Be sure to visit our social pages for more updates.

June 12, 2024